RP-6685 is a potent, selective and orally active DNA polymerase theta (Polθ) inhibitor with an IC 50 value of 5.8 nM (PicoGreen assay). RP-6685 shows antitumor efficacy in mouse tumor xenograft model.
性状
Solid
IC50 & Target[1][2]
IC50: 5.8 nM (Polθ)
体外研究(In Vitro)
RP-6685 is extremely potent with an IC50 of 550 pM against the pol activity of full-length Polθ and inactive on the ATPase activity.RP-6685 inhibits Polθ in HEK293 LIG4 cellswith an IC50 of 0.94 μM. has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)
RP-6685 (80 mg/kg; p.o.; BID for 21 days) exhibits potent antitumor efficacy in BRCA2-deficient HCT116 mice. has not independently confirmed the accuracy of these methods. They are for reference only.
Animal Model: Female CD1 nude mice (HCT1
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;4°C 2 years
参考文献
[1]. Bubenik M, et al. Identification of RP-6685, an Orally Bioavailable Compound that Inhibits the DNA Polymerase Activity of Polθ. J Med Chem. 2022 Sep 20.
溶解度数据
In Vitro: DMSO : 100 mg/mL (201.06 mM; Need ultrasonic)配制储备液